The recombinant protein is synthesized via cloning the rabbit CX3CR1 gene into bacterial vectors, followed by affinity chromatography purification. This method ensures high yield and consistency, critical for structural studies and assay standardization .
Advantages of Recombinant Production:
Animal origin-free: Avoids ethical concerns and batch variability .
Enhanced immunoreactivity: Rabbit-derived antibodies exhibit broader target recognition due to a larger immune repertoire .
Recombinant CX3CR1 is widely used to study:
Immune cell trafficking: Mediates adhesion and migration of monocytes, NK cells, and microglia via fractalkine binding .
Viral pathogenesis: Acts as a co-receptor for HIV-1/HIV-2 and respiratory syncytial virus (RSV), facilitating viral entry .
Inflammatory diseases: Linked to atherosclerosis, age-related macular degeneration, and autoimmune disorders .
Key Research Findings:
RSV Infection: CX3CR1 expression in cotton rat lungs correlates with RSV titers; knockdown reduces viral load by 10-fold .
HIV Interaction: Fractalkine binding inhibits HIV-1 envelope fusion, suggesting therapeutic potential .
Neuroinflammation: CX3CR1 signaling regulates microglial activation in spinal cord injury models .
While recombinant CX3CR1 enables mechanistic studies, its bacterial expression lacks post-translational modifications (e.g., glycosylation), potentially altering ligand-binding kinetics . Future work may employ mammalian or insect cell systems to address this. Additionally, its role in CX3CL1-independent pathways (e.g., angiogenesis modulation) remains underexplored .